Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;108(2):88-89.
doi: 10.1136/heartjnl-2021-320255. Epub 2021 Oct 16.

Does aspirin save lives in patients with COVID-19?

Dinesh Voruganti  1 , Pier Paolo Bassareo  2 , Giuseppe Calcaterra  3 , J L Mehta  4
Affiliations
Editorial

Does aspirin save lives in patients with COVID-19?

Dinesh Voruganti et al. Heart. 2022 Jan.
No abstract available

Keywords: COVID-19; healthcare; outcome assessment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

  • Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry.
    Santoro F, Nuñez-Gil IJ, Vitale E, Viana-Llamas MC, Reche-Martinez B, Romero-Pareja R, Feltez Guzman G, Fernandez Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, Garcia-Aguado M, Huang J, Ortega-Armas ME, Garcia Prieto JF, Corral Rubio EM, Ugo F, Bianco M, Mulet A, Raposeiras-Roubin S, Jativa Mendez JL, Espejo Paeres C, Albarrán AR, Marín F, Guerra F, Akin I, Cortese B, Ramakrishna H, Macaya C, Fernandez-Ortiz A, Brunetti ND. Santoro F, et al. Heart. 2022 Jan;108(2):130-136. doi: 10.1136/heartjnl-2021-319552. Epub 2021 Oct 5. Heart. 2022. PMID: 34611045 Free PMC article.

References

    1. Cate Hten. Surviving Covid-19 with heparin? N Engl J Med Overseas Ed 2021;385:845–6. 10.1056/NEJMe2111151 - DOI - PMC - PubMed
    1. Santoro F, Nuñez-Gil IJ, Vitale E, et al. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation registry. Heart 2022;108:130–6. 10.1136/heartjnl-2021-319552 - DOI - PMC - PubMed
    1. Viecca M, Radovanovic D, Forleo GB, et al. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. Pharmacol Res 2020;158:104950. 10.1016/j.phrs.2020.104950 - DOI - PMC - PubMed
    1. Liu X, Li Z, Liu S, et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B 2020;10:1205–15. 10.1016/j.apsb.2020.04.008 - DOI - PMC - PubMed
    1. Russo V, Di Maio M, Attena E, et al. Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: a multicenter observational study. Pharmacol Res 2020;159:104965. 10.1016/j.phrs.2020.104965 - DOI - PMC - PubMed